BLUE - bluebird bio, Inc.
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Annual
| Revenue | 31/12/2017 | 31/12/2016 | 31/12/2015 |
| Total revenue | 35,427 | 6,155 | 14,079 |
| Cost of revenue | 1,527 | - | - |
| Gross profit | 33,900 | 6,155 | 14,079 |
| Operating expenses | |||
| Research development | 273,040 | 204,775 | 134,038 |
| Selling general and administrative | 93,025 | 69,210 | 49,078 |
| Non-recurring | - | - | - |
| Others | - | - | - |
| Total operating expenses | - | - | - |
| Operating income or loss | -332,165 | -267,830 | -169,037 |
| Income from continuing operations | |||
| Total other income/expenses net | -1,267 | -71 | 723 |
| Earnings before interest and taxes | -335,433 | -264,119 | -166,723 |
| Interest expense | - | - | - |
| Income before tax | -335,433 | -264,119 | -166,723 |
| Income tax expense | 210 | -612 | 60 |
| Minority interest | - | - | - |
| Net income from continuing ops | -335,643 | -263,507 | -166,783 |
| Non-recurring events | |||
| Discontinued operations | - | - | - |
| Extraordinary items | - | - | - |
| Effect of accounting changes | - | - | - |
| Other items | - | - | - |
| Net income | |||
| Net income | -335,643 | -263,507 | -166,783 |
| Preferred stock and other adjustments | - | - | - |
| Net income applicable to common shares | -335,643 | -263,507 | -166,783 |
